Fry, D J
Clamp, Andrew R
Jayson, Gordon C
MetadataShow full item record
AbstractBackground:Thrombotic events are common in cancer patients and have been associated with an adverse prognosis in large registry-based studies.Methods:A retrospective cohort of 417 patients with ovarian cancer treated at a tertiary cancer centre between 2006 and 2009 was studied to identify the incidence and risk factors for thrombotic events and the prognostic impact of thrombosis. Patient outcomes were evaluated against a matched control group without thrombosis.Results:Ninety-nine thrombotic events occurred in 90 patients (21.6%) from 8 months before diagnosis to 56 months following diagnosis, peaking in the 4 months following diagnosis. Patients with thrombosis were older (mean 65 vs 61 years, P=0.007), had a worse performance status (PS 2: 29.9% vs 9.5%, P<0.0001) and had a more advanced FIGO stage (FIGO III/IV 75.6% vs 56.9%, P<0.0001) than patients without thrombosis. Shorter overall survival was seen in patients with pulmonary embolism and pelvic/lower limb deep vein thrombosis than without thrombosis (P=0.001). When the control group was matched for stage and PS, no survival difference was seen (P=0.91).Conclusion:Ovarian cancer patients with thrombotic events had a shorter survival. However, when matched for prognostic factors (PS and FIGO stage), thrombosis did not impact upon prognosis.British Journal of Cancer advance online publication, 21 January 2014; doi:10.1038/bjc.2014.3 www.bjcancer.com.
CitationThrombosis in ovarian cancer: a case control study. 2014: Br J Cancer
JournalBritish Journal of Cancer
- Comparison between thrombotic risk scores in essential thrombocythemia and survival implications.
- Authors: Santoro M, Accurso V, Mancuso S, Carlisi M, Raso S, Tarantino G, Di Piazza F, Perez A, Russo A, Siragusa S
- Issue date: 2019 Oct
- Thrombosis as a treatment complication in Hodgkin lymphoma patients: a comprehensive analysis of three prospective randomized German Hodgkin Study Group (GHSG) trials.
- Authors: Borchmann S, Müller H, Hude I, Fuchs M, Borchmann P, Engert A
- Issue date: 2019 Aug 1
- Ovarian vein thrombosis after debulking surgery for ovarian cancer: epidemiology and clinical significance.
- Authors: Mantha S, Sarasohn D, Ma W, Devlin SM, Chi DS, Roche KL, Suidan RS, Woo K, Soff GA
- Issue date: 2015 Aug
- Ovarian Vein Thrombosis: Incidence of Recurrent Venous Thromboembolism and Survival.
- Authors: Lenz CJ, Wysokinski WE, Henkin S, Cohoon KP, Casanegra A, Simmons BS, Saadiq RA, Daniels PR, Wysokinska EM, Bjarnason H, McBane RD
- Issue date: 2017 Nov
- Pre-treatment prognostic nutritional index is superior to platelet count in predicting disease-specific survival in patients with epithelial ovarian cancer.
- Authors: Komura N, Mabuchi S, Yokoi E, Shimura K, Kawano M, Matsumoto Y, Kimura T
- Issue date: 2019 Jul